K-cell + Omics Analysis for Bio-markers Determination

  • MiniPDX Mouse Trial (Learn More) enables an easy way for clients to determine indication(s) that is/are potentially fit for their new drug in future clinical trials, while to find the best bio-marker(s) for patient stratification in such indication(s) requires either transcriptome or genomic analysis using the same tumor samples before treatment(s). As no such commercialized kits for extract RNA or DNA from only thousands of cells are available, LIDE has developed a K-Cell systems to overcome the dilemma, followed with Functional Genomic Imaging for clustering analysis based on RNAseq raw data. Clients may utilize K-cell + Omics analysis (Learn More) to facilitate bio-marker(s) discovery in pre-clinical stage. 

K-cell + Omics Analysis for Bio-markers Determination